Detalles de la búsqueda
1.
Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors.
J Surg Oncol
; 129(6): 1121-1130, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38348696
2.
Comparison of age-stratified survival outcomes of gallbladder cancers in an Indian population.
HPB (Oxford)
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38834414
3.
Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumours.
Langenbecks Arch Surg
; 408(1): 204, 2023 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212896
4.
Modified FOLFIRINOX compared to Gemcitabine & nab-Paclitaxel in advanced pancreatic ductal adenocarcinoma - results of a match-pair analysis.
Indian J Med Res
; 157(1): 57-65, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37040228
5.
Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH).
Oncologist
; 27(3): 165-e222, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274724
6.
Pathological N3 Stage (pN3/ypN3) Gastric Cancer: Outcomes, Prognostic Factors and Pattern of Recurrences After Curative Treatment.
Ann Surg Oncol
; 29(1): 229-239, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34283313
7.
Hepatocellular Carcinoma Evaluation and Management for Physicians: Joint Gastroenterology Research Society and Association of Physicians of India Guidelines.
J Assoc Physicians India
; 70(5): 11-12, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598139
8.
Revision Surgery for Incidental Gallbladder Cancer-Challenging the Dogma: Ideal Timing and Real-World Applicability.
Ann Surg Oncol
; 28(11): 6758-6766, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33625635
9.
Long-term outcome of "Sandwich" chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease.
Eur J Nucl Med Mol Imaging
; 48(3): 913-923, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32876706
10.
Capecitabine-Temozolomide in Advanced Grade 2 and Grade 3 Neuroendocrine Neoplasms: Benefits of Chemotherapy in Neuroendocrine Neoplasms with Significant 18FDG Uptake.
Neuroendocrinology
; 111(10): 998-1004, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33017827
11.
Towards standardization of management of gallbladder carcinoma with obstructive jaundice: Analysis of 113 cases over 10 years at a single institution.
J Surg Oncol
; 124(4): 572-580, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34106475
12.
Outcomes of exenteration in cT4 and fixed cT3 stage primary rectal adenocarcinoma: a subgroup analysis of consolidation chemotherapy following neoadjuvant concurrent chemoradiotherapy.
Langenbecks Arch Surg
; 406(3): 821-831, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33733285
13.
Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine-Induced Hand-Foot Syndrome: Results of a Prospective Randomized Phase III Study.
Oncologist
; 25(12): e1886-e1892, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717127
14.
Clinico-pathological correlates and survival outcomes in 214 resected ampullary adenocarcinomas - are outcomes different in intestinal and pancreatobiliary subtypes with adjuvant gemcitabine?
HPB (Oxford)
; 22(3): 376-382, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31405778
15.
Emerging role of multimodality treatment in gall bladder cancer: Outcomes following 510 consecutive resections in a tertiary referral center.
J Surg Oncol
; 117(3): 372-379, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28940502
16.
Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer: Results from a single tertiary cancer centre.
Indian J Med Res
; 148(3): 284-290, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30425218
17.
Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications.
HPB (Oxford)
; 20(9): 841-847, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29706425
18.
Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and 'salvage' in patients with high risk locally advanced rectal cancers - tolerance and early outcomes.
J Cancer Res Ther
; 20(1): 199-203, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554321
19.
Non-operative management in low-lying rectal cancers undergoing chemoradiation.
J Cancer Res Ther
; 20(1): 417-422, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38554355
20.
Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases.
Eur J Surg Oncol
; 50(6): 108343, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640606